Trial Profile
Enhanced slow wave sleep and improved sleep maintenance after gaboxadol administration during seven nights of exposure to a traffic noise model of transient insomnia
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 Sep 2012
Price :
$35
*
At a glance
- Drugs Gaboxadol - Ovid Therapeuticsgaboxadol (Primary)
- Indications Insomnia
- Focus Therapeutic Use
- 07 Sep 2012 New trial record